HRP930253A2 - IMMUNOLOGICAL METHOD TO DETERMINE HbAIc - Google Patents
IMMUNOLOGICAL METHOD TO DETERMINE HbAIc Download PDFInfo
- Publication number
- HRP930253A2 HRP930253A2 HR930253A HRP930253A HRP930253A2 HR P930253 A2 HRP930253 A2 HR P930253A2 HR 930253 A HR930253 A HR 930253A HR P930253 A HRP930253 A HR P930253A HR P930253 A2 HRP930253 A2 HR P930253A2
- Authority
- HR
- Croatia
- Prior art keywords
- hemoglobin
- sample
- content
- hemolyzing
- hemolyzing reagent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 32
- 230000001900 immune effect Effects 0.000 title claims description 20
- 108010054147 Hemoglobins Proteins 0.000 claims description 102
- 102000001554 Hemoglobins Human genes 0.000 claims description 102
- 239000003153 chemical reaction reagent Substances 0.000 claims description 41
- 230000002949 hemolytic effect Effects 0.000 claims description 41
- 238000012360 testing method Methods 0.000 claims description 39
- 210000004369 blood Anatomy 0.000 claims description 37
- 239000008280 blood Substances 0.000 claims description 37
- 239000003599 detergent Substances 0.000 claims description 36
- 239000011535 reaction buffer Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 238000010521 absorption reaction Methods 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 8
- 239000007987 MES buffer Substances 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000035122 glycosylated proteins Human genes 0.000 claims description 4
- 108091005608 glycosylated proteins Proteins 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 230000010534 mechanism of action Effects 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000000523 sample Substances 0.000 description 38
- 239000003795 chemical substances by application Substances 0.000 description 15
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 14
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000005259 measurement Methods 0.000 description 9
- 238000011534 incubation Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 6
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 6
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 230000002349 favourable effect Effects 0.000 description 6
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 6
- AWDBHOZBRXWRKS-UHFFFAOYSA-N tetrapotassium;iron(6+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] AWDBHOZBRXWRKS-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000008105 immune reaction Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000008118 PEG 6000 Substances 0.000 description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical compound CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- 230000004520 agglutination Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000005375 photometry Methods 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- CKRJGDYKYQUNIM-UHFFFAOYSA-N 3-fluoro-2,2-dimethylpropanoic acid Chemical compound FCC(C)(C)C(O)=O CKRJGDYKYQUNIM-UHFFFAOYSA-N 0.000 description 2
- 108010061951 Methemoglobin Proteins 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- RCLDHCIEAUJSBD-UHFFFAOYSA-N 6-(6-sulfonaphthalen-2-yl)oxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=CC2=CC(OC3=CC4=CC=C(C=C4C=C3)S(=O)(=O)O)=CC=C21 RCLDHCIEAUJSBD-UHFFFAOYSA-N 0.000 description 1
- BUADUHVXMFJVLH-UHFFFAOYSA-N 7-chloro-3-imidazol-1-yl-2H-1,2,4-benzotriazin-1-ium 1-oxide Chemical compound N1[N+](=O)C2=CC(Cl)=CC=C2N=C1N1C=CN=C1 BUADUHVXMFJVLH-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 108700042971 cyanomethemoglobin Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- YHAIUSTWZPMYGG-UHFFFAOYSA-L disodium;2,2-dioctyl-3-sulfobutanedioate Chemical compound [Na+].[Na+].CCCCCCCCC(C([O-])=O)(C(C([O-])=O)S(O)(=O)=O)CCCCCCCC YHAIUSTWZPMYGG-UHFFFAOYSA-L 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- IZWSFJTYBVKZNK-UHFFFAOYSA-N lauryl sulfobetaine Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- ZJZXSOKJEJFHCP-UHFFFAOYSA-M lithium;thiocyanate Chemical compound [Li+].[S-]C#N ZJZXSOKJEJFHCP-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical group O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4206932A DE4206932A1 (de) | 1992-03-05 | 1992-03-05 | Immunologische methode zur bestimmung eines haemoglobinderivates |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP930253A2 true HRP930253A2 (en) | 1995-10-31 |
Family
ID=6453281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR930253A HRP930253A2 (en) | 1992-03-05 | 1993-03-03 | IMMUNOLOGICAL METHOD TO DETERMINE HbAIc |
Country Status (23)
Country | Link |
---|---|
US (1) | US5541117A (pt) |
EP (1) | EP0559164B1 (pt) |
JP (1) | JP2637677B2 (pt) |
KR (1) | KR930020162A (pt) |
CN (1) | CN1081765A (pt) |
AT (1) | ATE193378T1 (pt) |
AU (1) | AU652092B2 (pt) |
CA (1) | CA2090981C (pt) |
CZ (1) | CZ29193A3 (pt) |
DE (2) | DE4206932A1 (pt) |
DK (1) | DK0559164T3 (pt) |
ES (1) | ES2148190T3 (pt) |
FI (1) | FI930975A (pt) |
HR (1) | HRP930253A2 (pt) |
HU (1) | HUT70463A (pt) |
IL (1) | IL104902A0 (pt) |
NO (1) | NO930770L (pt) |
NZ (1) | NZ247054A (pt) |
PL (1) | PL297915A1 (pt) |
PT (1) | PT559164E (pt) |
SI (1) | SI9300108A (pt) |
SK (1) | SK14993A3 (pt) |
ZA (1) | ZA931533B (pt) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739037A (en) * | 1992-09-29 | 1998-04-14 | Drew Scientific Limited | Process for eliminating labile glycohaemoglobin from a sample |
US5610076A (en) * | 1994-04-29 | 1997-03-11 | Alteon Inc. | Method for detecting hemoglobin advanced glycosylation endproducts |
FR2721112B1 (fr) * | 1994-06-13 | 1996-08-14 | Gks Technologies | Dispositif de diagnostic rapide de toute molécule glyquée et procédé de mise en Óoeuvre. |
JP3150857B2 (ja) * | 1994-10-19 | 2001-03-26 | 富士写真フイルム株式会社 | グリコヘモグロビン含有比測定用分析要素及び分析方法 |
EP0729031A1 (en) * | 1995-02-24 | 1996-08-28 | F. Hoffmann-La Roche Ag | Set of reagents determining the content of total haemoglobin |
JP3269765B2 (ja) | 1995-12-14 | 2002-04-02 | 富士写真フイルム株式会社 | ヘモグロビン誘導体の免疫学的測定方法及びその方法に用いる処理試薬 |
JP3551678B2 (ja) * | 1996-03-14 | 2004-08-11 | 東ソー株式会社 | ヘモグロビンA1cの測定法及びキット |
US6855562B1 (en) | 1996-07-30 | 2005-02-15 | Horiba, Ltd. | Immunoassay method for lyzed whole blood |
JP3249919B2 (ja) * | 1996-07-30 | 2002-01-28 | 株式会社堀場製作所 | 免疫測定方法 |
US5858794A (en) * | 1997-05-13 | 1999-01-12 | Bayer Corporation | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers |
EP0905514B1 (en) * | 1997-09-27 | 2003-11-26 | Horiba, Ltd. | Blood cell count/immunoassay apparatus using whole blood |
US6485923B1 (en) * | 2000-02-02 | 2002-11-26 | Lifescan, Inc. | Reagent test strip for analyte determination having hemolyzing agent |
JPWO2002021142A1 (ja) * | 2000-09-07 | 2004-01-15 | 和光純薬工業株式会社 | 総ヘモグロビン及び糖化ヘモグロビンの測定方法 |
WO2004042364A2 (en) * | 2002-11-05 | 2004-05-21 | Therasense, Inc. | Assay device, system and method |
ES2335011T3 (es) * | 2003-05-27 | 2010-03-18 | Mitsubishi Kagaku Iatron, Inc. | Procedimiento inmunocromatografico. |
WO2005031356A1 (en) * | 2003-09-23 | 2005-04-07 | Epinex Diagnostic, Inc. | Rapid test for glycated albumin |
CA2544353A1 (en) * | 2003-10-29 | 2005-05-12 | Mec Dynamics Corp. | Micro mechanical methods and systems for performing assays |
US7541190B2 (en) * | 2005-02-07 | 2009-06-02 | Beckman Coulter, Inc. | Method of measurement of cellular hemoglobin |
WO2006112339A1 (ja) * | 2005-04-14 | 2006-10-26 | Matsushita Electric Industrial Co., Ltd. | ヘモグロビン誘導体の測定方法、それに用いる試薬組成物、測定キット、分析デバイス、及び分析システム |
CN101484793B (zh) * | 2006-03-24 | 2012-07-04 | 爱科来株式会社 | 糖基血红蛋白浓度测定方法和浓度测定装置 |
EP2012111B1 (en) * | 2006-03-24 | 2014-07-16 | ARKRAY, Inc. | Method of measuring glycohemoglobin concentration and apparatus for concentration measurement |
US20100012049A1 (en) * | 2006-04-12 | 2010-01-21 | Jms Co., Ltd | Cavitation heating system and method |
WO2008016193A1 (en) | 2006-07-29 | 2008-02-07 | I-Sens, Inc. | Electrochemical determination system of glycated proteins |
US8273577B2 (en) * | 2007-01-30 | 2012-09-25 | Arkray, Inc. | Method for detecting phenothiazine-derivative color and color-developer reagent used therein |
JP5465008B2 (ja) | 2007-10-30 | 2014-04-09 | パナソニック株式会社 | ヘモグロビン及びヘモグロビン誘導体の測定方法、測定キット |
CN101493467A (zh) * | 2008-01-25 | 2009-07-29 | 上海伊思柏生物科技有限公司 | 定量测定糖化蛋白质的方法 |
KR101005559B1 (ko) | 2008-07-15 | 2011-01-05 | 주식회사 아이센스 | 바이오센서를 이용한 단백질 측정 장치 |
US20110269147A1 (en) * | 2008-07-18 | 2011-11-03 | Bayer Healthcare Llc | Methods, Devices, and Systems for Glycated Hemoglobin Analysis |
US9341633B2 (en) | 2008-12-11 | 2016-05-17 | Sekisui Medical Co., Ltd. | Method for pre-treating sample containing glycated hemoglobin |
US20100167306A1 (en) * | 2008-12-26 | 2010-07-01 | Henry John Smith | Rapid test for glycated albumin in saliva |
WO2010135574A2 (en) * | 2009-05-20 | 2010-11-25 | Relia Diagnostic Systems, Inc. | Systems and methods for determining the percentage of glycated hemoglobin |
EP2562539B1 (en) * | 2010-03-31 | 2023-09-27 | Sekisui Medical Co., Ltd. | Method of analyzing hemoglobins |
JP5906604B2 (ja) * | 2011-08-11 | 2016-04-20 | 東洋紡株式会社 | 全血検体の成分測定方法 |
KR101207418B1 (ko) | 2012-02-10 | 2012-12-04 | 주식회사 아이센스 | 효소법을 이용하는 당화혈색소 정량분석용 용혈시약 조성물 |
EP3140661B1 (de) | 2014-05-06 | 2018-08-15 | DiaSys Diagnostic Systems GmbH | Enzymatische bestimmung von hba1c |
CN104062430B (zh) * | 2014-06-30 | 2016-03-30 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测样品中流感病毒的试剂盒及其检测方法和应用 |
EP3397971B1 (en) * | 2015-12-30 | 2021-08-04 | W. Health L.P. | Method for determining the quantity of an hba1c in a blood sample |
US20210278422A1 (en) * | 2018-09-12 | 2021-09-09 | Sekisui Medical Co., Ltd. | Reagent and method for measuring hemoglobins |
CN110702894A (zh) * | 2019-10-10 | 2020-01-17 | 南京欧凯生物科技有限公司 | 一种直接测定糖化血红蛋白含量的检测方法 |
CN112067566A (zh) * | 2020-08-28 | 2020-12-11 | 南开大学 | 一种用于糖化血红蛋白定量分析的比色传感器 |
CN113984689B (zh) * | 2021-10-25 | 2023-11-03 | 中元汇吉生物技术股份有限公司 | 一种测定谷胱甘肽还原酶的试剂盒 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4247533A (en) * | 1978-05-01 | 1981-01-27 | The Rockefeller University | Hemoglobin A1c radioimmunoassay |
US4200435A (en) * | 1978-12-26 | 1980-04-29 | Abbott Laboratories | Determination of glycosylated hemoglobin in blood |
JPS5861465A (ja) * | 1981-10-07 | 1983-04-12 | Mitsubishi Chem Ind Ltd | 血液の分析方法 |
US4478744A (en) * | 1982-01-25 | 1984-10-23 | Sherwood Medical Company | Method of obtaining antibodies |
HU186976B (en) * | 1982-10-01 | 1985-10-28 | Reanal Finomvegyszergyar | Process for determation of glucose containt of glucolized in non-ensimatic way proteins and reagent lutes for this process |
US4529705A (en) * | 1983-06-06 | 1985-07-16 | Coulter Electronics, Inc. | Reagent for combined diluting and lysing whole blood |
US4647654A (en) * | 1984-10-29 | 1987-03-03 | Molecular Diagnostics, Inc. | Peptides useful in preparing hemoglobin A1c immunogens |
US4658022A (en) * | 1985-08-08 | 1987-04-14 | Molecular Diagnostics, Inc. | Binding of antibody reagents to denatured protein analytes |
CA1339952C (en) * | 1984-10-29 | 1998-07-14 | William J. Knowles | Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto |
US4727036A (en) * | 1985-08-08 | 1988-02-23 | Molecular Diagnostics, Inc. | Antibodies for use in determining hemoglobin A1c |
JPS61148369A (ja) * | 1984-12-06 | 1986-07-07 | テクニコン・インストウルメンツ・コーポレイシヨン | シアニドを含まないヘモグロビン試薬 |
DK145385D0 (da) * | 1985-03-29 | 1985-04-01 | Novo Industri As | Monoklonalt antistof til immunkemisk analyse |
DE3532868A1 (de) * | 1985-09-14 | 1987-03-26 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin sowie hierzu geeignete verbindungen und verfahren zu deren herstellung |
US4806468A (en) * | 1987-02-05 | 1989-02-21 | Becton, Dickinson And Company | Measurement of glycosylated hemoglobin by immunoassay |
US4861728A (en) * | 1987-07-24 | 1989-08-29 | Becton, Dickinson And Company | Immunoassay of glycosylated hemoglobin using a labeled boron reagent |
DE3733084A1 (de) * | 1987-09-30 | 1989-04-13 | Boehringer Mannheim Gmbh | Testtraeger zur analytischen bestimmung eines bestandteils einer koerperfluessigkeit |
US4970171A (en) * | 1987-11-09 | 1990-11-13 | Miles Inc. | Denaturant reagents for convenient determination of hemoglobin derivatives in blood |
JP2619900B2 (ja) * | 1988-01-27 | 1997-06-11 | 東亜医用電子株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬および方法 |
NO890029D0 (no) * | 1989-01-04 | 1989-01-04 | Axis Research | Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes). |
IL94724A (en) * | 1989-07-13 | 1994-02-27 | Miles Inc | Decomposition of red blood cells and denaturation of hemoglobin by the use of lithium salts |
JP2836865B2 (ja) * | 1989-10-23 | 1998-12-14 | 東亜医用電子株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
JP2891302B2 (ja) * | 1990-03-01 | 1999-05-17 | シスメックス株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
US5242832A (en) * | 1990-03-01 | 1993-09-07 | Toa Medical Electronics Co., Ltd. | Reagent for measurement of leukocytes and hemoglobin in blood |
DE69121456T2 (de) * | 1990-05-09 | 1996-12-19 | Hoffmann La Roche | Stabilisiertes Harnsäurereagens |
DE4135542A1 (de) * | 1991-10-28 | 1993-04-29 | Boehringer Mannheim Gmbh | Lagerfaehige proteinloesungen |
-
1992
- 1992-03-05 DE DE4206932A patent/DE4206932A1/de not_active Withdrawn
-
1993
- 1993-02-26 CZ CZ93291A patent/CZ29193A3/cs unknown
- 1993-03-01 IL IL104902A patent/IL104902A0/xx unknown
- 1993-03-01 SK SK14993A patent/SK14993A3/sk unknown
- 1993-03-01 AU AU33871/93A patent/AU652092B2/en not_active Ceased
- 1993-03-02 PL PL29791593A patent/PL297915A1/xx unknown
- 1993-03-03 DE DE59310046T patent/DE59310046D1/de not_active Expired - Lifetime
- 1993-03-03 PT PT93103349T patent/PT559164E/pt unknown
- 1993-03-03 DK DK93103349T patent/DK0559164T3/da active
- 1993-03-03 HR HR930253A patent/HRP930253A2/hr not_active Application Discontinuation
- 1993-03-03 NZ NZ247054A patent/NZ247054A/en not_active IP Right Cessation
- 1993-03-03 EP EP93103349A patent/EP0559164B1/de not_active Expired - Lifetime
- 1993-03-03 ES ES93103349T patent/ES2148190T3/es not_active Expired - Lifetime
- 1993-03-03 AT AT93103349T patent/ATE193378T1/de active
- 1993-03-03 NO NO93930770A patent/NO930770L/no unknown
- 1993-03-04 FI FI930975A patent/FI930975A/fi unknown
- 1993-03-04 ZA ZA931533A patent/ZA931533B/xx unknown
- 1993-03-04 CN CN93104037A patent/CN1081765A/zh active Pending
- 1993-03-04 CA CA002090981A patent/CA2090981C/en not_active Expired - Lifetime
- 1993-03-04 HU HU9300596A patent/HUT70463A/hu unknown
- 1993-03-04 US US08/026,464 patent/US5541117A/en not_active Expired - Lifetime
- 1993-03-05 JP JP5045130A patent/JP2637677B2/ja not_active Expired - Fee Related
- 1993-03-05 KR KR1019930003336A patent/KR930020162A/ko not_active Application Discontinuation
- 1993-03-05 SI SI9300108A patent/SI9300108A/sl unknown
Also Published As
Publication number | Publication date |
---|---|
ATE193378T1 (de) | 2000-06-15 |
EP0559164B1 (de) | 2000-05-24 |
CZ29193A3 (en) | 1994-01-19 |
FI930975A (fi) | 1993-09-06 |
US5541117A (en) | 1996-07-30 |
HUT70463A (en) | 1995-10-30 |
EP0559164A2 (de) | 1993-09-08 |
PL297915A1 (en) | 1993-09-06 |
AU652092B2 (en) | 1994-08-11 |
HU9300596D0 (en) | 1993-05-28 |
KR930020162A (ko) | 1993-10-19 |
DK0559164T3 (da) | 2000-10-30 |
JPH0611510A (ja) | 1994-01-21 |
EP0559164A3 (pt) | 1994-01-26 |
PT559164E (pt) | 2000-10-31 |
CA2090981C (en) | 1999-11-16 |
JP2637677B2 (ja) | 1997-08-06 |
ZA931533B (en) | 1994-09-04 |
CA2090981A1 (en) | 1993-09-06 |
IL104902A0 (en) | 1993-07-08 |
DE4206932A1 (de) | 1993-09-09 |
AU3387193A (en) | 1993-09-16 |
CN1081765A (zh) | 1994-02-09 |
ES2148190T3 (es) | 2000-10-16 |
DE59310046D1 (de) | 2000-06-29 |
NZ247054A (en) | 1995-02-24 |
SI9300108A (en) | 1993-09-30 |
NO930770D0 (no) | 1993-03-03 |
NO930770L (no) | 1993-09-06 |
FI930975A0 (fi) | 1993-03-04 |
SK14993A3 (en) | 1993-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP930253A2 (en) | IMMUNOLOGICAL METHOD TO DETERMINE HbAIc | |
JPH06502244A (ja) | グリカン化血中タンパク質のアッセイ | |
JPH08122335A (ja) | グリコヘモグロビン含有比測定用分析要素及び分析方法 | |
WO2019138898A1 (ja) | イムノクロマト試験片および測定キットおよび測定方法 | |
ES2541114T3 (es) | Métodos para la detección de hemoglobina glicosilada | |
CZ374392A3 (en) | Method of determining concentration of different substances | |
EP0455225B1 (en) | Method for measuring the percentage of glycation of a particular protein | |
US4166106A (en) | Immunologic determination method | |
Paek et al. | Performance control strategies of one-step immuno-chromatographic assay system for Salmonella typhimurium | |
US6027907A (en) | Method for immunological determination of hemoglobin derivative and treating reagent for use therein | |
JP4214648B2 (ja) | 糖化蛋白質測定試薬 | |
JPWO2020066722A1 (ja) | ヘモグロビンの測定試薬、測定キット及び測定方法 | |
EP0061071B1 (en) | Activated apoglucose oxidase, method of preparing it, its use in specific binding assay methods and reagent means and test kits containing it | |
Perini et al. | Reducing the artifacts produced by impure antisera in immunoblots of low-molecular-mass proteins in urine. | |
Dolhofer-Bliesener et al. | Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation | |
JPH11118806A (ja) | ヘモグロビンの安定化方法 | |
JPH09224942A (ja) | ヒトヘモグロビンの安定化方法 | |
JP7508494B2 (ja) | ヘモグロビンの測定試薬、測定キット及び測定方法 | |
EP1162462B1 (en) | Assay method for hemoglobin using lipoproteins | |
WO2019107414A1 (ja) | ヘモグロビンとハプトグロビンとの複合体を安定化する方法、及びヘモグロビンを含む検体を保存するための保存溶液 | |
CA2117745A1 (en) | Treating of lipoprotein containing samples | |
Doihofer-Bliesener et al. | Impaired Immunoglobulin G Fc Fragment Function in Diabetics is Caused by a Mechanism Different from Glycation | |
Moscoso et al. | Peroxidase/monoclonal antibody conjugates for the study of hemoglobinopathies | |
JPH0556799A (ja) | 糖化タンパク質の検出試薬 | |
CA2120348A1 (en) | Immunological method of analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
OBST | Application withdrawn |